Zobrazeno 1 - 10
of 320
pro vyhledávání: '"Sigal DS"'
Publikováno v:
In Blood 19 May 2011 117(20):5551-5551
Autor:
Hermel DJ; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Cham J; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Spierling Bagsic SR; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Hong LK; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Costantini CL; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Mason JR; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Saven A; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA., Sigal DS; Division of Hematology & Oncology, Scripps Clinic, La Jolla, CA 92037, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2022 Feb; Vol. 18 (6), pp. 719-725. Date of Electronic Publication: 2022 Feb 02.
Autor:
Sigal DS; Director, GI Oncology, Scripps Clinic & Scripps MD Anderson Cancer Center, 10710 N Torrey Pines Road, La Jolla, CA 92037, USA., Hermel DJ; Scripps Clinic & Scripps MD Anderson Cancer Center, 10710 N Torrey Pines Road, LA Jolla, CA 92037, USA., Hsu P; Medical Advisor, Medical Affairs & Clinical Development, OBI Pharma Inc. 7F, No. 369, Zhongxiao E Road, Nangang District, Taipei City, 115, Taiwan., Pearce T; Chief Medical Officer, OBI Pharma USA Inc., 6020 Cornerstone Court W, Suite 200, San Diego, CA 92121, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2022 Jan; Vol. 18 (1), pp. 117-134. Date of Electronic Publication: 2021 Nov 04.
Autor:
Hermel DJ; Division of Hematology and Oncology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, CA, USA., Du EZ; Division of Pathology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, CA, USA., Lin R; Division of Radiation Oncology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, CA, USA., Frenette CT; Division of Gastroenterology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, CA, USA., Sigal DS; Division of Hematology and Oncology, Scripps Clinic and Scripps MD Anderson Cancer Center, La Jolla, CA, USA.
Publikováno v:
Journal of clinical and translational hepatology [J Clin Transl Hepatol] 2021 Apr 28; Vol. 9 (2), pp. 265-268. Date of Electronic Publication: 2021 Feb 01.
Hairy cell leukemia is a rare disease for which there are multiple treatment options. Purine nucleoside analogs (cladribine and pentostatin) are generally used for front-line treatment. Other active agents include interferon, rituximab and, although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c25c3bf2f5c1430188531613e25c6326
http://hdl.handle.net/11585/100017
http://hdl.handle.net/11585/100017
Autor:
Wang, Junke1,2,3 (AUTHOR), Yang, Jie4,5 (AUTHOR), Narang, Amol2,3,6 (AUTHOR), He, Jin2,3,6,7 (AUTHOR), Wolfgang, Christopher8 (AUTHOR), Li, Keyu2,3,4 (AUTHOR) keyu_li@scu.edu.cn, Zheng, Lei2,3,6,7,9 (AUTHOR) lzheng6@jhmi.edu
Publikováno v:
Journal of Hematology & Oncology. 10/11/2024, Vol. 17 Issue 1, p1-59. 59p.
Autor:
Marvin-Peek, Jennifer1 (AUTHOR), Jen, Wei-Ying1 (AUTHOR), Kantarjian, Hagop M.1 (AUTHOR), McCue, David1 (AUTHOR), Haddad, Fadi G.1 (AUTHOR), Wierda, William1 (AUTHOR), Ferrajoli, Alessandra1 (AUTHOR), Burger, Jan1 (AUTHOR), Abusab, Tareq2 (AUTHOR), Jorgensen, Jeffrey3 (AUTHOR), Wang, Sa A.3 (AUTHOR), Patel, Keyur3 (AUTHOR), Loghavi, Sanam3 (AUTHOR), O'Brien, Susan4 (AUTHOR), Ravandi, Farhad1 (AUTHOR) fravandi@mdanderson.org
Publikováno v:
Leukemia & Lymphoma. Sep2024, Vol. 65 Issue 9, p1325-1334. 10p.
Autor:
Sigal DS; Division of Hematology/Oncology, Scripps Clinic Medical Group, La Jolla, CA, USA., Bhangoo MS; Division of Hematology/Oncology, Scripps Clinic Medical Group, La Jolla, CA, USA., Hermel JA; Department of Graduate Medical Education, Tulane University School of Medicine, New Orleans, LA, USA., Pavlick DC; Foundation Medicine, Inc. Cambridge, MA, USA., Frampton G; Foundation Medicine, Inc. Cambridge, MA, USA., Miller VA; Foundation Medicine, Inc. Cambridge, MA, USA., Ross JS; Foundation Medicine, Inc. Cambridge, MA, USA., Ali SM; Foundation Medicine, Inc. Cambridge, MA, USA.
Publikováno v:
Oncotarget [Oncotarget] 2018 Nov 09; Vol. 9 (88), pp. 35809-35812. Date of Electronic Publication: 2018 Nov 09 (Print Publication: 2018).
Autor:
Hingorani SR; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Zheng L; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Bullock AJ; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Seery TE; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Harris WP; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Sigal DS; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Braiteh F; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Ritch PS; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Zalupski MM; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Bahary N; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Oberstein PE; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Wang-Gillam A; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Wu W; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Chondros D; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Jiang P; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Khelifa S; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Pu J; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Aldrich C; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ., Hendifar AE; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; William P. Harris, University of Washington, School of Medicine, Seattle, WA; Lei Zheng, Johns Hopkins University School of Medicine, Baltimore, MD; Andrea J. Bullock, Beth Israel Deaconess Medical Center, Boston, MA; Tara E. Seery, Chan Soon-Shiong Institute for Medicine, El Segundo; Darren S. Sigal, Scripps Cancer Center, La Jolla; Wilson Wu, Dimitrios Chondros, and Ping Jiang, Halozyme Therapeutics, San Diego; Andrew E. Hendifar, Cedars-Sinai Medical Center and Samuel Oschin Cancer Center, Los Angeles, CA; Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Paul S. Ritch, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, WI; Mark M. Zalupski, University of Michigan, Ann Arbor, MI; Nathan Bahary, University of Pittsburgh Medical Center Cancer Pavilion, Pittsburgh, PA; Paul E. Oberstein, Columbia University Medical Center, New York, NY; Andrea Wang-Gillam, Washington University, St Louis, MO; and Sihem Khelifa, Jie Pu, and Carrie Aldrich, Ventana Medical Systems, Tucson, AZ.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Feb 01; Vol. 36 (4), pp. 359-366. Date of Electronic Publication: 2017 Dec 12.